Meta-Analysis

getty | piotr malczyk

Review: Antioxidants and biotics offer benefits for MAFLD patients

By Nikki Hancocks

Antioxidants and pro-, pre- and synbiotics may be promising in the treatment of metabolic-associated fatty liver disease (MAFLD) but the benefits of fatty acids and vitamin D are less conclusive, according to a new review and meta-analysis.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All